retrospective-study-evaluates-diagnostic-indexes-and-clinical-features-in-thirty-three-osteomalacia-cases
Retrospective Study Evaluates Diagnostic Indexes and Clinical Features in Thirty-Three Osteomalacia Cases

Retrospective Study Evaluates Diagnostic Indexes and Clinical Features in Thirty-Three Osteomalacia Cases

A fifteen-year retrospective study conducted at a hospital rheumatology department has demonstrated that structured clinical indexes can reliably aid in diagnosing osteomalacia, a generalized metabolic bone disorder characterized by defective mineralization of the organic bone matrix. Investigators analyzed the medical records of thirty-three patients diagnosed with the condition between the ages of 17 and 87 years, recording an average patient age of 50.6 years and a pronounced female predominance indicated by a female-to-male sex ratio of 0.18. Osteomalacia represents a qualitative bone impairment where unmineralized osteoid accumulates abnormally throughout the skeleton, contrasting sharply with osteoporosis, which is primarily defined by a quantitative deficit in bone mass. The initial suspicion of the disorder was prompted by overt clinical symptoms in twenty-eight individuals, while unexpected biochemical findings of hypocalcemia prompted suspicion in three patients and isolated radiological findings initiated the investigation in the remaining two.

The symptomatic manifestations documented across the cohort illustrated the severe physical impact of impaired skeletal mineralization, which frequently mimics other musculoskeletal disorders and complicates early clinical identification. Diffuse bone pain was the single most pervasive presenting complaint, affecting 87.8 percent of the patient cohort, followed closely by gait disturbances in 63.6 percent and identifiable motor deficits in 54.5 percent of individuals. In addition, muscle pain was recorded in 42.2 percent of patients, while clinically apparent bone deformities were observed in 21.2 percent and low-trauma fragility fractures occurred in 24.2 percent. The investigators noted that classic presentations often involve proximal myopathy and pelvic muscle weakness that produce a characteristic waddling gait. Because these symptoms lack distinct diagnostic specificity on physical examination alone, osteomalacia is routinely vulnerable to diagnostic confusion with conditions such as spondyloarthritis, polymyalgia rheumatica, polymyositis, fibromyalgia, and metastatic skeletal malignancy.

Conventional and specialized radiographic assessments revealed profound structural alterations throughout the skeleton among the studied patients. Diffuse bone demineralization was identified as the most frequent radiological sign, detected in 91 percent of the individuals evaluated, while distinct bone deformities appeared in 39.5 percent and skeletal fractures were documented in 55 percent. Pathognomonic Looser-Milkman zones, which appear as narrow, radiotransparent pseudofracture bands running transverse to the long axis of bone and frequently exhibiting bilateral symmetry, were identified in 60.6 percent of the cases. Imaging records detailed these specific pseudofractures in locations including the ulna and the femur, alongside lumbar vertebral compression fractures with fuzzy demineralization, bell-shaped thoracic cage deformities, and triradiate pelvic configurations with coxa profunda. Dual-energy X-ray absorptiometry performed in twenty patients demonstrated low bone mineral density in 85 percent and met the densitometric threshold for osteoporosis in 60 percent, illustrating how reduced bone density combined with fractures can misdirect clinical impressions toward osteoporosis.

Biochemical profiling demonstrated consistent alterations in mineral metabolism, reflecting secondary systemic adaptations to impaired skeletal calcium and phosphate deposition. Serum alkaline phosphatase activity was increased in 85 percent of the evaluated patients, representing a vital enzymatic marker of impaired mineralization when liver disease and pregnancy are ruled out. Serum calcium concentrations were abnormally depressed, with hypocalcemia documented in 88 percent of cases, whereas hypophosphatemia was identified in 61 percent of patients. Parathyroid hormone levels were notably elevated in 82 percent of tested individuals, establishing the widespread occurrence of secondary hyperparathyroidism triggered by low circulating calcium reserves. Testing for 25-hydroxyvitamin D revealed deficient concentrations across all fourteen patients who underwent the assay, confirming severe depletion of systemic vitamin D stores in every tested instance, although high costs and public hospital availability limits constrained routine testing across the entire cohort.

To overcome the invasiveness and limited technical availability of histomorphometric bone biopsies, the authors systematically applied and compared two established diagnostic scoring algorithms, the McKenna Index and the Adrar Index. The McKenna Index assigns weighted point values to clinical, biological, and radiological parameters, establishing a score of 35 or greater as indicative of osteomalacia, a score below 15 as unlikely, and intermediate scores between 15 and 35 as requiring histopathological confirmation through bone biopsy. Similarly, the Adrar Index designates a score of 25 or higher as positive confirmation, scores below 15 as low probability, and intermediate scores between 15 and 35 as indeterminate. Across the thirty-three patients, the mean McKenna score reached 53.52 with an overall range extending from 35 to 70, while the mean Adrar score was 48.08 with an observed range from 30 to 70. Every patient met the positive diagnostic criteria on both assessment systems simultaneously.

Statistical evaluation confirmed a significant positive correlation between the McKenna Index and the Adrar Index, yielding a correlation coefficient of r equals 0.560 and a significance value of p equals 0.01. Comparative subgroup testing revealed no significant differences in clinical, biochemical, or radiographic presentations when dividing the patient population between those aged 60 years or older and younger cohorts. Furthermore, calculated index scores did not differ significantly between patients whose disease stemmed from vitamin D metabolism disturbances and those affected by alternative pathogenic mechanisms. In contrast to non-invasive scoring, the recognized diagnostic gold standard of trans-iliac bone biopsy after tetracycline double labeling was carried out in only one patient in the entire cohort, which histologically confirmed the condition by demonstrating non-mineralized osteoid matrix expansion with characteristic areas of abnormal thickening.

Etiological investigations revealed that disorders directly related to vitamin D insufficiency represented the predominant driver of osteomalacia in the study population. Inadequate dietary intake of vitamin D combined with insufficient lifestyle exposure was determined to be the primary cause in 15 patients, accounting for 45.5 percent of the cohort, while sixteen patients reported maintaining sufficient sun exposure. Gastrointestinal malabsorption of vitamin D was diagnosed in nine individuals, representing 27.3 percent of cases, with underlying celiac disease accounting for seven of these occurrences, while one patient had undergone a surgical gastrectomy and another had cholestasis secondary to primary biliary cholangitis. Impaired hepatic 25-hydroxylation was linked specifically to the case of primary biliary cholangitis. Chronic kidney failure was identified in five patients, representing 15.1 percent of the series, where impaired renal 1-alpha-hydroxylation caused clinical, biochemical, and radiological features fully consistent with osteomalacia rather than other patterns of chronic kidney disease-mineral and bone disorder.

Renal phosphate wasting constituted an important non-vitamin D etiology, identified in four patients, or 12.1 percent of the total series. Within this group, one case was secondary to generalized proximal tubular dysfunction from Fanconi syndrome, two patients suffered from renal tubular acidosis, of which one was secondary to primary Sjögren’s syndrome, and one case presented as oncogenic osteomalacia driven by a mesenchymal tumor of the urinary bladder. Oncogenic osteomalacia represents a rare paraneoplastic hypophosphatemic syndrome caused by tumor-secreted phosphatonins, notably fibroblast growth factor 23, which suppress proximal tubular phosphate reabsorption and inhibit renal 1-alpha-hydroxylase activity. The researchers highlighted that testing for fibroblast growth factor 23 was not performed in any patient due to expense and public hospital assay unavailability, and no cases of dietary phosphate depletion or antacid-induced phosphorus chelation were observed in the series.

Therapeutic management combined targeted nutritional replenishment with disease-specific interventions tailored to underlying etiologies. Symptomatic pain management utilizing analgesic medications was prescribed for seven patients, while all thirty-three patients received daily oral calcium supplementation ranging from 1000 to 1500 milligrams. Vitamin D repletion protocols varied according to clinical presentation, utilizing daily oral ergocalciferol at doses of 4000 to 8000 units in 18 patients, intramuscular ergocalciferol injections of 200,000 units every four months in seven patients, 25-hydroxycholecalciferol at 75 micrograms daily in four patients, and 1-hydroxycholecalciferol at 0.25 to 0.5 micrograms daily in ten patients. Oral phosphate supplementation was required in one individual. Specific curative or targeted etiologic therapy was successfully administered in ten patients, encompassing strict adherence to a gluten-free exclusion diet in celiac disease, complete surgical tumor resection in oncogenic osteomalacia, and urinary alkalinization with sodium bicarbonate in renal tubular acidosis.

Clinical evolution data collected during patient follow-up indicated highly favorable therapeutic responses among those with available longitudinal records. Monitoring was maintained for thirteen patients over a mean follow-up period of 32.8 months, spanning an observed interval between 2 and 72 months. None of the monitored patients developed disease-related skeletal or metabolic complications following the initiation of therapy. All thirteen monitored individuals experienced complete resolution of bone and muscle pain alongside objective normalization of circulating biochemical parameters, demonstrating that restoring mineral homeostasis effectively arrests bone demineralization and alleviates symptomatic impairment over medium- and long-term horizons.

The study authors highlighted several methodological limitations that temper the conclusions drawn from this retrospective clinical series. The investigation was conducted as a single-center retrospective review over a 15-year period with a modest sample size of thirty-three patients, which inherently limits external generalizability and restricts the statistical power required for advanced multivariate modeling. Most notably, histopathological verification by bone biopsy was executed in only a single case, which prevented the direct calculation of diagnostic sensitivity, specificity, and predictive values for the McKenna and Adrar scoring systems against the formal histological gold standard. Furthermore, the absence of systematic genetic testing precluded the exploration of potential hereditary tubular or mineralization gene mutations, while economic barriers restricted the use of 25-hydroxyvitamin D assays and entirely prevented the measurement of fibroblast growth factor 23.

Subject of Research: Clinical, biochemical, and radiological evaluation of diagnostic approaches in osteomalacia

Article Title: Clinical, biochemical, and radiological features of osteomalacia: evaluation of diagnostic approaches in a retrospective study of 33 cases

Article References: Tekaya, R., Rouached, L., Ben Dhia, S., Jemmali, M., Aissa, M. A., Bouden, S., Ben Tekaya, A., Mahmoud, I., & Abdelmoula, L. (2026). Clinical, biochemical, and radiological features of osteomalacia: evaluation of diagnostic approaches in a retrospective study of 33 cases. Egyptian Rheumatology and Rehabilitation, 53(1), Article 62. https://doi.org/10.1186/s43166-026-00431-y

Image Credits: AI Generated

DOI: 10.1186/s43166-026-00431-y

Keywords: osteomalacia, defective bone mineralization, McKenna Index, Adrar Index, alkaline phosphatase, hypocalcemia, hypophosphatemia, Looser-Milkman zones, bone demineralization, secondary hyperparathyroidism, vitamin D deficiency, celiac disease, renal phosphate leak, oncogenic osteomalacia, bone densitometry, bone biopsy